Description
LUNAIR-M is a combination medication designed to manage asthma, allergic rhinitis, and other respiratory disorders effectively. It combines Montelukast (10mg), a leukotriene receptor antagonist, and Acebrophylline (200mg), a bronchodilator and anti-inflammatory agent.
Montelukast (10mg): Montelukast works by blocking leukotrienes, chemicals in the body that contribute to inflammation and narrowing of the airways in conditions like asthma and allergic rhinitis. By inhibiting these substances, Montelukast helps reduce symptoms like wheezing, shortness of breath, and nasal congestion. It also helps prevent asthma attacks and improves overall lung function.
Acebrophylline (200mg): Acebrophylline is a bronchodilator that helps to relax and widen the airways, making it easier to breathe. It also possesses anti-inflammatory properties, reducing swelling and irritation in the lungs. The combination of bronchodilation and anti-inflammatory effects makes Acebrophylline highly effective in treating chronic respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD).
Together, LUNAIR-M offers a dual-action solution for managing respiratory conditions, improving airflow, preventing inflammation, and helping patients breathe more easily. It is particularly beneficial for those suffering from asthma, seasonal allergies, or chronic respiratory conditions, providing both symptomatic relief and long-term management of lung function.
